INTERNATIONAL PATENT: GUANGZHOU BIOSYNGEN CO., LTD., 广州百吉生物制药有限公司 FILES APPLICATION FOR "PROTEIN COMBINATION, NUCLEIC ACID ENCODING SAME, RECOMBINANT VECTOR COMPRISING NUCLEIC ACID, RECOMBINANT LENTIVIRUS, ENGINEERED IMMUNE CELL AND USE THEREOF"

GENEVA, May 3 -- GUANGZHOU BIOSYNGEN CO., LTD. (Room 318-321, Building2, No.1 Tengfei Street, Sino-Singapore Knowledge City Huangpu DistrictGuangzhou, Guangdong 510555), 广州百吉生物制药有限公司 (中国广东省广州市黄埔区中新广州知识城腾飞一街2号318-321房) filed a patent application (PCT/CN2024/126328) for "PROTEIN COMBINATION, NUCLEIC ACID ENCODING SAME, RECOMBINANT VECTOR COMPRISING NUCLEIC ACID, RECOMBINANT LENTIVIRUS, ENGINEERED IMMUNE CELL AND USE THEREOF" on Oct 22, 2024. With publication no. WO/2026/085698, the details relat...